New Issue: Orbital Catastrophe Ahead? Read Now

Sight Savers

Technology that could help the blind see is now in the laboratory

Join Our Community of Science Lovers!


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


Conventional wisdom specifies that the central nervous system—the brain, spinal cord and eye nerves—cannot heal in adults. This thinking no longer holds. Larry I. Benowitz of Children's Hospital Boston and his colleagues found a molecule that triggers better nerve regeneration than any other studied. The scientists discovered that a protein, oncomodulin, is secreted in damaged eyes by immune cells known as macrophages. They found that oncomodulin, when given with compounds that enhance its activity, can increase nerve regeneration fivefold to sevenfold in rats with injured optic nerves (right). Benowitz believes oncomodulin could someday help reverse optic nerve damage caused by glaucoma, tumors or trauma and plans to investigate whether the treatment could work to help treat stroke and spinal cord injury.

Another invention affords hope that some blind people may be able to view images and video. Visually challenged artist and poet Elizabeth Goldring, a senior fellow at the Massachusetts Institute of Technology's Center for Advanced Visual Studies, developed just such a “seeing machine.” It projects images directly onto the retina using light-emitting diodes, similar to much more costly scanning laser ophthalmoscopes used by medical institutions. In a pilot clinical trial of the seeing machine with 10 volunteers, most of whom were legally blind because of retinopathy and other causes, six correctly interpreted all 10 examples from a specially crafted visual language that combines words and pictures.

Prosthetics of another kind may in the future enable an amputee to use electrical signals from remaining muscles so that he or she can move an artificial arm more naturally. Protagoras Cutchis of Johns Hopkins University developed an electrode array implanted around the sheath of a peripheral nerve that does not penetrate into the nerve itself, unlike previous technologies. The electrode can process signals from electrical impulses from the brain that might eventually direct an arm to perform up to 22 distinct motions, far superior to previous prostheses that could move in only three directions. Machines are thus proving ever more able to take up the slack when the human body falters.

Charles Q. Choi is a frequent contributor to Scientific American. His work has also appeared in The New York Times, Science, Nature, Wired, and LiveScience, among others. In his spare time, he has traveled to all seven continents.

More by Charles Q. Choi
Scientific American Magazine Vol 295 Issue 6This article was published with the title “Sight Savers” in Scientific American Magazine Vol. 295 No. 6 (), p. 58
doi:10.1038/scientificamerican1206-58b

Subscribe to Support Independent Journalism

Great science journalism requires human expertise, time, effort and creativity. And it costs money. That’s why I and the journalists here at Scientific American hope you’ll join our community.

When you subscribe, you are supporting staff and freelance journalists who are passionate about telling science stories that are true, important and compelling. Our editors and reporters are often experts in their fields, which means they understand the nuances of big discoveries and can untangle the breakthroughs from the hype. With a subscription, you are also supporting rigorous fact-checking to ensure the words we publish are precise and accurate. And you’re supporting original illustrations, graphics and photos that bring you closer to an advanced laboratory, an ice sheet in Antarctica or a space mission in orbit. You’re helping us craft other types of high-quality journalism as well: Our newsletters are carefully written, edited and curated by staffers you have or will come to know and love. Our Science Quickly podcast is based on original reporting, collaboration with editors and scientists and exacting production.

Subscriptions keep this engine running so we can continue to deliver thoughtful, rigorous and independent science journalism to you. In an era of viral misinformation, this work is crucial. If you value what we do, I hope you’ll consider joining us as a subscriber

Thank you,

Jeanna Bryner, Editor in Chief, Scientific American

Subscribe